Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 124192, 6 pages
http://dx.doi.org/10.1155/2015/124192
Review Article

Novel PET/SPECT Probes for Imaging of Tau in Alzheimer’s Disease

Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan

Received 25 June 2014; Revised 10 September 2014; Accepted 30 September 2014

Academic Editor: Mei Tian

Copyright © 2015 Hiroyuki Watanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Min Wang, Mingzhang Gao, Zhidong Xu, and Qi-Huang Zheng, “Synthesis of a PET tau tracer [11C]PBB3 for imaging of Alzheimer’s disease,” Bioorganic & Medicinal Chemistry Letters, 2015. View at Publisher · View at Google Scholar
  • Killian Oukoloff, Monika Cieslikiewicz-Bouet, Sovy Chao, Emilie Da Costa Bran-quinho, Cedric Bouteiller, Ludovic Jean, and Pierre-Yves Renard, “PET and SPECT Radiotracers for Alzheimer's Disease,” Current Medicinal Chemistry, vol. 22, no. 28, pp. 3278–3304, 2015. View at Publisher · View at Google Scholar
  • Harmeet Kaur, Balasubramanian Narasimhan, and Snehlata Yadav, “Diazenyl derivatives as therapeutic and diagnostic agents acting on central nervous system,” Central Nervous System Agents in Medicinal Chemistry, vol. 15, no. 1, pp. 42–51, 2015. View at Publisher · View at Google Scholar
  • Laura B. Eisenmenger, Eugene J. Huo, John M. Hoffman, Satoshi Minoshima, Manuela C. Matesan, David H. Lewis, Brian J. Lopresti, Chester A. Mathis, David O. Okonkwo, and James M. Mountz, “Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia,” Seminars in Nuclear Medicine, vol. 46, no. 1, pp. 57–87, 2016. View at Publisher · View at Google Scholar
  • Masahiro Ono, Yuki Doi, Hiroyuki Watanabe, Masafumi Ihara, Akihiko Ozaki, and Hideo Saji, “Structure–activity relationships of radioiodinated diphenyl derivatives with different conjugated double bonds as ligands for α-synuclein aggregates,” RSC Adv., vol. 6, no. 50, pp. 44305–44312, 2016. View at Publisher · View at Google Scholar
  • Amy L. Vāvere, and Peter J.H. Scott, “Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook,” Seminars in Nuclear Medicine, 2017. View at Publisher · View at Google Scholar
  • Emily Fisher, Yanyan Zhao, Robert Richardson, Malgorzata Janik, Alexander K. Buell, Franklin I. Aigbirhio, and Gergely Tóth, “Detection and Characterization of Small Molecule Interactions with Fibrillar Protein Aggregates Using Microscale Thermophoresis,” ACS Chemical Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Mingzhang Gao, Min Wang, and Qi-Huang Zheng, “Synthesis of carbon-11-labeled isonicotinamides as new potential PET agents for imaging of GSK-3 enzyme in Alzheimer’s disease,” Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 4, pp. 740–743, 2017. View at Publisher · View at Google Scholar
  • Chen-Chen Tan, Xiao-Yan Zhang, Lan Tan, and Jin-Tai Yu, “Tauopathies: Mechanisms and Therapeutic Strategies,” Journal of Alzheimer's Disease, pp. 1–22, 2017. View at Publisher · View at Google Scholar
  • Atul K. Mallik, Alexander Drzezga, and Satoshi Minoshima, “Molecular Imaging and Precision Medicine in Dementia and Movement Disorders,” PET Clinics, vol. 12, no. 1, pp. 119–136, 2017. View at Publisher · View at Google Scholar
  • M.L. Bolognesi, “From Imaging Agents to Theranostic Drugs in Alzheimer's Disease,” Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, 2017. View at Publisher · View at Google Scholar
  • K. Rajasekhar, and Thimmaiah Govindaraju, “Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease,” RSC Advances, vol. 8, no. 42, pp. 23780–23804, 2018. View at Publisher · View at Google Scholar